MX2024004878A - Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) anal. - Google Patents
Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) anal.Info
- Publication number
- MX2024004878A MX2024004878A MX2024004878A MX2024004878A MX2024004878A MX 2024004878 A MX2024004878 A MX 2024004878A MX 2024004878 A MX2024004878 A MX 2024004878A MX 2024004878 A MX2024004878 A MX 2024004878A MX 2024004878 A MX2024004878 A MX 2024004878A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- squamous intraepithelial
- grade squamous
- intraepithelial lesion
- hsil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163270929P | 2021-10-22 | 2021-10-22 | |
| PCT/US2022/078551 WO2023070109A1 (en) | 2021-10-22 | 2022-10-21 | Compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024004878A true MX2024004878A (es) | 2024-07-15 |
Family
ID=86059748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024004878A MX2024004878A (es) | 2021-10-22 | 2022-10-21 | Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) anal. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230233659A1 (https=) |
| EP (1) | EP4419138A4 (https=) |
| JP (1) | JP2024539188A (https=) |
| KR (1) | KR20240099266A (https=) |
| CN (1) | CN118382457A (https=) |
| AU (1) | AU2022371672A1 (https=) |
| CA (1) | CA3235779A1 (https=) |
| CO (1) | CO2024006161A2 (https=) |
| MX (1) | MX2024004878A (https=) |
| WO (1) | WO2023070109A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58080B1 (sr) * | 2014-11-04 | 2019-02-28 | Janssen Vaccines & Prevention Bv | Terapeutske vakcine protiv hpv16 |
| JP6470872B2 (ja) * | 2015-08-20 | 2019-02-13 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 治療用ｈｐｖ１８ワクチン |
| WO2018209322A1 (en) * | 2017-05-11 | 2018-11-15 | Inovio Pharmaceuticals, Inc. | Clinical and immunologic biomarkers for regression of high grade cervical dysplasia and clearance of hpv16 and hpv18 infection after immunotherapy |
| WO2021202949A2 (en) * | 2020-04-02 | 2021-10-07 | Inovio Pharmaceuticals, Inc. | Compositions and methods for treating vulvar dysplasia |
-
2022
- 2022-10-21 JP JP2024523770A patent/JP2024539188A/ja active Pending
- 2022-10-21 KR KR1020247015465A patent/KR20240099266A/ko active Pending
- 2022-10-21 MX MX2024004878A patent/MX2024004878A/es unknown
- 2022-10-21 WO PCT/US2022/078551 patent/WO2023070109A1/en not_active Ceased
- 2022-10-21 EP EP22884739.8A patent/EP4419138A4/en active Pending
- 2022-10-21 CA CA3235779A patent/CA3235779A1/en active Pending
- 2022-10-21 CN CN202280082724.8A patent/CN118382457A/zh active Pending
- 2022-10-21 US US18/048,776 patent/US20230233659A1/en active Pending
- 2022-10-21 AU AU2022371672A patent/AU2022371672A1/en active Pending
-
2024
- 2024-05-15 CO CONC2024/0006161A patent/CO2024006161A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230233659A1 (en) | 2023-07-27 |
| WO2023070109A1 (en) | 2023-04-27 |
| EP4419138A4 (en) | 2026-03-04 |
| AU2022371672A1 (en) | 2024-05-16 |
| KR20240099266A (ko) | 2024-06-28 |
| JP2024539188A (ja) | 2024-10-28 |
| EP4419138A1 (en) | 2024-08-28 |
| CO2024006161A2 (es) | 2024-06-27 |
| CA3235779A1 (en) | 2023-04-27 |
| CN118382457A (zh) | 2024-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020047161A3 (en) | Engineered immunostimulatory bacterial strains and uses thereof | |
| MX2022014248A (es) | Vacunas para la papilomatosis respiratoria recurrente y metodos para usar estas. | |
| SA519401379B1 (ar) | علاج فيروس مرتبط بغدة لمرض هنتنجتون | |
| EP4104854A3 (en) | Multivalent vaccines for rabies virus and coronaviruses | |
| MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
| MX2022002211A (es) | Composiciones y metodos para tratar infecciones virales. | |
| BR112016026721A2 (pt) | vacinas com base em vesículas do tipo vírus (vlvs) para prevenir ou tratar infecção por vírus da hepatite b (hbv) crônica | |
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| PH12019500592A1 (en) | New swine influenza vaccine | |
| MX2020009262A (es) | Vectores de parapoxvirus. | |
| EP4269438A3 (en) | Oncolytic virus and method | |
| WO2021202949A3 (en) | Compositions and methods for treating vulvar dysplasia | |
| ZA202209180B (en) | Compositions and methods for treating long covid | |
| Ellerhoff et al. | Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus | |
| WO2021081480A3 (en) | Improved vaccines for recurrent respiratory papillomatosis and methods for using the same | |
| PH12017501165A1 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| WO2020079489A3 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| MX2024004878A (es) | Composiciones y métodos para el tratamiento de la lesión escamosa intraepitelial de alto grado (hsil) anal. | |
| JP2025188115A (ja) | 新規遺伝子組換えワクシニアウイルス及びその利用 | |
| MX360449B (es) | Vacunas para el virus del papiloma humano y metodos para su uso. | |
| Kumar et al. | DNA vaccine: a modern biotechnological approach towards human welfare and clinical trials | |
| BR112022019334A2 (pt) | Método para produzir um genoma viral interferente defeituoso, genomas virais interferentes defeituosos, partícula interferente defeituosa, método de tratamento de uma infecção viral, genoma interferente defeituoso, composição farmacêutica, imunogênica ou terapêutica, vacina, uso, polinucleotídeo, vetor de expressão ou plasmídeo e linhagem de células | |
| MX2021008126A (es) | Vacuna de arnm. | |
| WO2021158755A3 (en) | Leptospiral proteins and uses thereof | |
| MX2024002621A (es) | Partículas similares a virus para el tratamiento o prevención de una infección por un virus coronaviridae. |